Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer

D.R. Camidge, H.R. Kim, M.-J. Ahn, J.C.-H. Yang, J.-Y. Han, J.-S. Lee, M.J. Hochmair, J.Y.-C. Li, G.-C. Chang, K.H. Lee, C. Gridelli, A. Delmonte, R. Garcia Campelo, D.-W. Kim, A. Bearz, F. Griesinger, A. Morabito, E. Felip, R. Califano, S. GhoshA. Spira, S.N. Gettinger, M. Tiseo, N. Gupta, J. Haney, D. Kerstein, S. Popat

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)2027-2039
Number of pages13
JournalNew England Journal of Medicine
Volume379
Issue number21
DOIs
Publication statusPublished - 2018

Cite this

Camidge, D. R., Kim, H. R., Ahn, M-J., Yang, JC-H., Han, J-Y., Lee, J-S., ... Popat, S. (2018). Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer. New England Journal of Medicine, 379(21), 2027-2039. https://doi.org/10.1056/NEJMoa1810171

Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer. / Camidge, D.R.; Kim, H.R.; Ahn, M.-J.; Yang, J.C.-H.; Han, J.-Y.; Lee, J.-S.; Hochmair, M.J.; Li, J.Y.-C.; Chang, G.-C.; Lee, K.H.; Gridelli, C.; Delmonte, A.; Garcia Campelo, R.; Kim, D.-W.; Bearz, A.; Griesinger, F.; Morabito, A.; Felip, E.; Califano, R.; Ghosh, S.; Spira, A.; Gettinger, S.N.; Tiseo, M.; Gupta, N.; Haney, J.; Kerstein, D.; Popat, S.

In: New England Journal of Medicine, Vol. 379, No. 21, 2018, p. 2027-2039.

Research output: Contribution to journalArticle

Camidge, DR, Kim, HR, Ahn, M-J, Yang, JC-H, Han, J-Y, Lee, J-S, Hochmair, MJ, Li, JY-C, Chang, G-C, Lee, KH, Gridelli, C, Delmonte, A, Garcia Campelo, R, Kim, D-W, Bearz, A, Griesinger, F, Morabito, A, Felip, E, Califano, R, Ghosh, S, Spira, A, Gettinger, SN, Tiseo, M, Gupta, N, Haney, J, Kerstein, D & Popat, S 2018, 'Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer', New England Journal of Medicine, vol. 379, no. 21, pp. 2027-2039. https://doi.org/10.1056/NEJMoa1810171
Camidge, D.R. ; Kim, H.R. ; Ahn, M.-J. ; Yang, J.C.-H. ; Han, J.-Y. ; Lee, J.-S. ; Hochmair, M.J. ; Li, J.Y.-C. ; Chang, G.-C. ; Lee, K.H. ; Gridelli, C. ; Delmonte, A. ; Garcia Campelo, R. ; Kim, D.-W. ; Bearz, A. ; Griesinger, F. ; Morabito, A. ; Felip, E. ; Califano, R. ; Ghosh, S. ; Spira, A. ; Gettinger, S.N. ; Tiseo, M. ; Gupta, N. ; Haney, J. ; Kerstein, D. ; Popat, S. / Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer. In: New England Journal of Medicine. 2018 ; Vol. 379, No. 21. pp. 2027-2039.
@article{8151e3e371d04fd7bab6593cab405c2a,
title = "Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer",
author = "D.R. Camidge and H.R. Kim and M.-J. Ahn and J.C.-H. Yang and J.-Y. Han and J.-S. Lee and M.J. Hochmair and J.Y.-C. Li and G.-C. Chang and K.H. Lee and C. Gridelli and A. Delmonte and {Garcia Campelo}, R. and D.-W. Kim and A. Bearz and F. Griesinger and A. Morabito and E. Felip and R. Califano and S. Ghosh and A. Spira and S.N. Gettinger and M. Tiseo and N. Gupta and J. Haney and D. Kerstein and S. Popat",
note = "Cited By :15 Export Date: 4 February 2019",
year = "2018",
doi = "10.1056/NEJMoa1810171",
language = "Italian",
volume = "379",
pages = "2027--2039",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "21",

}

TY - JOUR

T1 - Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer

AU - Camidge, D.R.

AU - Kim, H.R.

AU - Ahn, M.-J.

AU - Yang, J.C.-H.

AU - Han, J.-Y.

AU - Lee, J.-S.

AU - Hochmair, M.J.

AU - Li, J.Y.-C.

AU - Chang, G.-C.

AU - Lee, K.H.

AU - Gridelli, C.

AU - Delmonte, A.

AU - Garcia Campelo, R.

AU - Kim, D.-W.

AU - Bearz, A.

AU - Griesinger, F.

AU - Morabito, A.

AU - Felip, E.

AU - Califano, R.

AU - Ghosh, S.

AU - Spira, A.

AU - Gettinger, S.N.

AU - Tiseo, M.

AU - Gupta, N.

AU - Haney, J.

AU - Kerstein, D.

AU - Popat, S.

N1 - Cited By :15 Export Date: 4 February 2019

PY - 2018

Y1 - 2018

U2 - 10.1056/NEJMoa1810171

DO - 10.1056/NEJMoa1810171

M3 - Articolo

VL - 379

SP - 2027

EP - 2039

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 21

ER -